Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Mepolizumab in Patients With Severe Eosinophilic Asthma Treated in Poland. The Real-life Observational Study

NCT05091385 is registered in ClinicalTrials.gov with Medical University of Lodz as lead sponsor.

NCT NCT05091385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05091385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Mepolizumab in Patients With Severe Eosinophilic Asthma Treated in Poland. The Real-life Observational Study
Lead sponsor
Medical University of Lodz
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
August 6, 2025
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma; eosinophilic